Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Arch Gynecol Obstet ; 285(6): 1603-9, 2012 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-22215197

RESUMO

PURPOSE: Rapamycin, an immunosuppressive in transplant surgery, has an additional antiproliferative effect. The aim of this study was to investigate the potential protective effects of rapamycin on postoperative adhesion development. METHODS: Ten rats per group underwent midline incision laparotomy and adhesion induction including bowel sutures. Therapy groups received daily intraperitoneal rapamycin injections (1.5 mg/kg body weight) for 3 weeks postoperatively. Controls were rats without any postoperative treatment, rats receiving the rapamycin solvent or a hyaluronic acid-carboxymethylcellulose membrane (Seprafilm(™)). RESULTS: Postoperative rapamycin application led to enhanced adhesion development and there was a higher rate of wound infections. In addition, Seprafilm(™) did not reduce adhesions, in subgroups there were even more. CONCLUSIONS: Rapamycin is not recommendable for perioperative immunosuppression, it enhances adhesion development and leads to a higher rate of wound infections. Surprisingly, the established Seprafilm(™) membrane led to more adhesions in our experimental setting.


Assuntos
Carboximetilcelulose Sódica/efeitos adversos , Ácido Hialurônico/efeitos adversos , Imunossupressores/efeitos adversos , Membranas Artificiais , Sirolimo/efeitos adversos , Aderências Teciduais/etiologia , Animais , Carboximetilcelulose Sódica/uso terapêutico , Feminino , Ácido Hialurônico/uso terapêutico , Imunossupressores/uso terapêutico , Laparotomia/efeitos adversos , Masculino , Ratos , Ratos Sprague-Dawley , Sirolimo/uso terapêutico , Infecção da Ferida Cirúrgica/etiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA